Back to User profile » Mr Guanglu Jiang
Papers published by Mr Guanglu Jiang:
Contezolid Harbored Equivalent Efficacy to Linezolid in Tuberculosis Treatment in a Prospective and Randomized Early Bactericidal Activity Study
Jiang G, Liu R, Xue Y, Ge Q, Nie L, Lv Z, Kong Z, Shi J, Chen H, Li H, Wu X, Xie L, Song Y, Huang H, Gao M
Infection and Drug Resistance 2025, 18:261-268
Published Date: 13 January 2025
In vitro and Intracellular Antibacterial Activity of Sudapyridine (WX-081) Against Tuberculosis
Xiao H, Yu X, Shang Y, Ren R, Xue Y, Dong L, Zhao L, Jiang G, Huang H
Infection and Drug Resistance 2023, 16:217-224
Published Date: 10 January 2023
Doubled Nontuberculous Mycobacteria Isolation as a Consequence of Changes in the Diagnosis Algorithm
Chen S, Wang F, Xue Y, Huo F, Jia J, Dong L, Zhao L, Jiang G, Huang H
Infection and Drug Resistance 2022, 15:3347-3355
Published Date: 27 June 2022
In vitro Antimicrobial Activity Comparison of Linezolid, Tedizolid, Sutezolid and Delpazolid Against Slowly Growing Mycobacteria Isolated in Beijing, China
Yu X, Huo F, Wang F, Wen S, Jiang G, Xue Y, Dong L, Zhao L, Zhu R, Huang H
Infection and Drug Resistance 2021, 14:4689-4697
Published Date: 9 November 2021
Carbonyl Cyanide 3-Chlorophenylhydrazone (CCCP) Exhibits Direct Antibacterial Activity Against Mycobacterium abscessus
Chen S, Teng T, Zhang Z, Shang Y, Xiao H, Jiang G, Wang F, Jia J, Dong L, Zhao L, Chu N, Huang H
Infection and Drug Resistance 2021, 14:1199-1208
Published Date: 23 March 2021
Para-aminosalicylic acid increases the susceptibility to isoniazid in clinical isolates of Mycobacterium tuberculosis
Zhang T, Jiang G, Wen S, Huo F, Wang F, Huang H, Pang Y
Infection and Drug Resistance 2019, 12:825-829
Published Date: 11 April 2019